These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32788871)

  • 1. Articulation recovery in ALS patients after lineage-negative adjuvant cell therapy - preliminary report.
    Pawlukowska W; Baumert B; Gołąb-Janowska M; Pius-Sadowska E; Litwińska Z; Kotowski M; Meller A; Rotter I; Peregud-Pogorzelski J; Nowacki P
    Int J Med Sci; 2020; 17(13):1927-1935. PubMed ID: 32788871
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of Lineage-Negative Stem Cell Therapy on Articulatory Functions in ALS Patients.
    Pawlukowska W; Baumert B; Gołąb-Janowska M; Sobuś A; Wełnicka A; Meller A; Machowska-Sempruch K; Zawiślak A; Łuczkowska K; Milczarek S; Osękowska B; Paczkowska E; Rotter I; Nowacki P; Machaliński B
    Stem Cells Int; 2019; 2019():7213854. PubMed ID: 31281384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Feasibility of Lin- Cells Administration to ALS Patients: A Novel View on Humoral Factors and miRNA Profiles.
    Sobuś A; Baumert B; Litwińska Z; Gołąb-Janowska M; Stępniewski J; Kotowski M; Pius-Sadowska E; Kawa MP; Gródecka-Szwajkiewicz D; Peregud-Pogorzelski J; Dulak J; Nowacki P; Machaliński B
    Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29702606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral Influence of Repeated Lineage-Negative Stem/Progenitor Cell Administration on Articulatory Functions in ALS Patients.
    Sobuś A; Baumert B; Pawlukowska W; Gołąb-Janowska M; Paczkowska E; Wełnicka A; Meller A; Machowska-Sempruch K; Zawiślak A; Łuczkowska K; Milczarek S; Osękowska B; Safranow K; Rotter I; Nowacki P; Machaliński B
    Stem Cells Int; 2020; 2020():8888271. PubMed ID: 33381192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local and Systemic Humoral Response to Autologous Lineage-Negative Cells Intrathecal Administration in ALS Patients.
    Baumert B; Sobuś A; Gołąb-Janowska M; Ulańczyk Z; Paczkowska E; Łuczkowska K; Zawiślak A; Milczarek S; Osękowska B; Meller A; Machowska-Sempruch K; Wełnicka A; Safranow K; Nowacki P; Machaliński B
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32041109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I trial of repeated intrathecal autologous bone marrow-derived mesenchymal stromal cells in amyotrophic lateral sclerosis.
    Oh KW; Moon C; Kim HY; Oh SI; Park J; Lee JH; Chang IY; Kim KS; Kim SH
    Stem Cells Transl Med; 2015 Jun; 4(6):590-7. PubMed ID: 25934946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated Application of Autologous Bone Marrow-Derived Lineage-Negative Stem/Progenitor Cells-Focus on Immunological Pathways in Patients with ALS.
    Baumert B; Sobuś A; Gołąb-Janowska M; Paczkowska E; Łuczkowska K; Rogińska D; Zawiślak A; Milczarek S; Osękowska B; Pawlukowska W; Meller A; Machowska-Sempruch K; Wełnicka A; Safranow K; Nowacki P; Machaliński B
    Cells; 2020 Aug; 9(8):. PubMed ID: 32752182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative assessment and monitoring of deterioration of articulatory organs using subjective and objective tools among patients with amyotrophic lateral sclerosis.
    Pawlukowska W; Baumert B; Gołąb-Janowska M; Meller A; Machowska-Sempruch K; Wełnicka A; Paczkowska E; Rotter I; Machaliński B; Nowacki P
    BMC Neurol; 2019 Oct; 19(1):241. PubMed ID: 31629403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeat Administration of Bone Marrow-Derived Mesenchymal Stem Cells for Treatment of Amyotrophic Lateral Sclerosis.
    Siwek T; Jezierska-Woźniak K; Maksymowicz S; Barczewska M; Sowa M; Badowska W; Maksymowicz W
    Med Sci Monit; 2020 Dec; 26():e927484. PubMed ID: 33301428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the therapeutic potential of different administration routes and frequencies of human mesenchymal stromal cells in the SOD1
    Bursch F; Rath KJ; Sarikidi A; Böselt S; Kefalakes E; Osmanovic A; Thau-Habermann N; Klöß S; Köhl U; Petri S
    J Tissue Eng Regen Med; 2019 Apr; 13(4):649-663. PubMed ID: 30811816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated Intrathecal Mesenchymal Stem Cells for Amyotrophic Lateral Sclerosis.
    Oh KW; Noh MY; Kwon MS; Kim HY; Oh SI; Park J; Kim HJ; Ki CS; Kim SH
    Ann Neurol; 2018 Sep; 84(3):361-373. PubMed ID: 30048006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Evidence of the Increase in Angiogenic Factor Plasma Levels after Lineage-Negative Stem/Progenitor Cell Intracoronary Infusion in Patients with Acute Myocardial Infarction.
    Baumert B; Przybycień K; Paczkowska E; Kotowski M; Pius-Sadowska E; Safranow K; Peregud-Pogorzelski J; Kornacewicz-Jach Z; Peregud-Pogorzelska M; Machaliński B
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant Lineage-Negative Cell Therapy as a Potential Silencer of the Complement-Mediated Immune System in ALS Patients.
    Sobuś A; Baumert B; Gołąb-Janowska M; Kulig P; Paczkowska E; Łuczkowska K; Rogińska D; Zawiślak A; Milczarek S; Osękowska B; Pawlukowska W; Meller A; Machowska-Sempruch K; Wełnicka A; Nowacki P; Machaliński B
    J Clin Med; 2021 Nov; 10(22):. PubMed ID: 34830531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosis: Results of Phase 1/2 and 2a Clinical Trials.
    Petrou P; Gothelf Y; Argov Z; Gotkine M; Levy YS; Kassis I; Vaknin-Dembinsky A; Ben-Hur T; Offen D; Abramsky O; Melamed E; Karussis D
    JAMA Neurol; 2016 Mar; 73(3):337-44. PubMed ID: 26751635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down regulation of trophic factors in neonatal rat spinal cord after administration of cerebrospinal fluid from sporadic amyotrophic lateral sclerosis patients.
    Deepa P; Shahani N; Alladi PA; Vijayalakshmi K; Sathyaprabha TN; Nalini A; Ravi V; Raju TR
    J Neural Transm (Vienna); 2011 Apr; 118(4):531-8. PubMed ID: 21069391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NurOwn, phase 2, randomized, clinical trial in patients with ALS: Safety, clinical, and biomarker results.
    Berry JD; Cudkowicz ME; Windebank AJ; Staff NP; Owegi M; Nicholson K; McKenna-Yasek D; Levy YS; Abramov N; Kaspi H; Mehra M; Aricha R; Gothelf Y; Brown RH
    Neurology; 2019 Dec; 93(24):e2294-e2305. PubMed ID: 31740545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Relationship between Selected Demographic Factors and Speech Organ Dysfunction in Sporadic ALS Patients.
    Pawlukowska W; Baumert B; Gołąb-Janowska M; Meller A; Machowska-Sempruch K; Wełnicka A; Paczkowska E; Rotter I; Machaliński B; Nowacki P
    Medicina (Kaunas); 2020 Aug; 56(8):. PubMed ID: 32764342
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety of intrathecal autologous adipose-derived mesenchymal stromal cells in patients with ALS.
    Staff NP; Madigan NN; Morris J; Jentoft M; Sorenson EJ; Butler G; Gastineau D; Dietz A; Windebank AJ
    Neurology; 2016 Nov; 87(21):2230-2234. PubMed ID: 27784774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological markers of mesenchymal stromal cells as predictors of response to autologous stem cell transplantation in patients with amyotrophic lateral sclerosis: an investigator-initiated trial and in vivo study.
    Kim HY; Kim H; Oh KW; Oh SI; Koh SH; Baik W; Noh MY; Kim KS; Kim SH
    Stem Cells; 2014 Oct; 32(10):2724-31. PubMed ID: 24966156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection of optimal passage of bone marrow-derived mesenchymal stem cells for stem cell therapy in patients with amyotrophic lateral sclerosis.
    Choi MR; Kim HY; Park JY; Lee TY; Baik CS; Chai YG; Jung KH; Park KS; Roh W; Kim KS; Kim SH
    Neurosci Lett; 2010 Mar; 472(2):94-8. PubMed ID: 20117176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.